Safety and efficacy of immune checkpoint inhibitors (ICIs) in patients (pts) with cardiac metastases (mets) from solid tumors

被引：0
|
作者：
Nassar, Amin
Abou Alaiwi, Sarah
El Zarif, Talal
Denu, Ryan Austin
Hayek, Salim S.
Goodman, Rachel S.
Woodford, Rachel
Neilan, Tomas G.
Haykal, Tarek
Kojima, Yuji
Trevino, Alexandra
Hui, Gavin
Tandon, Ankita
El-Am, Edward
Mittra, Arjun
Baena, Javier
Choudhary, Arrush
Grynberg, Shirly
Choueiri, Toni K.
Naqash, Abdul Rafeh
机构：
[1] Yale Canc Ctr, New Haven, CT USA
[2] Dana Farber Canc Inst, Lank Ctr Genitourinary Oncol, Boston, MA USA
[3] Brigham & Womens Hosp, Boston, MA USA
[4] Dana Farber Canc Inst, Boston, MA USA
[5] Harvard Med Sch, Boston, MA USA
[6] Univ Texas MD Anderson Canc Ctr, Houston, TX USA
[7] Michigan Med, Dept Cardiovasc Med, Ann Arbor, MI USA
[8] Vanderbilt Univ, Sch Med, Nashville, TN USA
[9] Melanoma Inst Australia, Wollstonecraft, NSW, Australia
[10] Massachusetts Gen Hosp, Behalf ATRIUM Investigators, Boston, MA USA
[11] Duke Univ, Durham, NC USA
[12] Japanese Red Cross Ise Hosp, Ise, Japan
[13] Northwestern Univ, Chicago, IL USA
[14] Univ Calif Los Angeles, Los Angeles, CA USA
[15] Loyola Univ Med Ctr, Maywood, IL USA
[16] Mayo Clin, Rochester, MN USA
[17] Ohio State Univ, Clumbus, OH USA
[18] Hosp Univ 12 Octubre, Dept Med Oncol, Madrid, Spain
[19] BIDMC, Boston, MA USA
[20] Ella Lemelbaum Inst Immuno Oncol & Melanoma, Sheba Med Ctr, Ramat Gan, Israel
[21] Dana Farber Canc Inst, Harvard Med Sch, Boston, MA USA
[22] Univ Oklahoma Hlth Sci, Stephenson Canc Ctr, Oklahoma City, OK USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2653
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Efficacy and safety of immune checkpoint inhibitors (ICIs) for treatment of advanced solid tumours in octogenarian patients
    Mebarki, S.
    Gisselbrecht, M.
    Fabre, E.
    Mercadier, E.
    Oudard, S.
    Paillaud, E.
    ANNALS OF ONCOLOGY, 2019, 30 : 524 - +
  • [2] Early incidence of immune-related adverse events (irAEs) predicts efficacy in patients (pts) with solid tumors treated with immune-checkpoint inhibitors (ICIs).
    Morehouse, Chris
    Abdullah, Shaad Essa
    Gao, Chen
    Dar, Mohammed M.
    Ranade, Koustubh
    Higgs, Brandon W.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [3] SAFETY AND EFFICACY OF IMMUNE CHECKPOINT INHIBITORS (ICIS) IN PATIENTS WITH PRE-EXISTING ORGAN DYSFUNCTION
    Kesireddy, Meghana
    Ganti, Apar
    Marr, Alissa
    Schissel, Makayla
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A1290 - A1291
  • [4] Comparative efficacy, safety, and tolerability of immune checkpoint inhibitors (ICIs) in cancer.
    Al-Showbaki, Laith
    Nadler, Michelle
    Desnoyers, Alexandra
    Almugbel, Fahad
    Cescon, David W.
    Amir, Eitan
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [5] Efficacy and safety of immune checkpoint inhibitors in advanced solid tumors with hepatitis B infection
    Niu, Ruiqi
    Du, Yingying
    Qian, Hesheng
    Pang, Jingdan
    Zeng, Xinyan
    Chen, Sheng
    Wang, Jing
    Wu, Wentian
    Shao, Changchun
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [6] Efficacy and safety of immune checkpoint inhibitors (ICIs) combined with antiangiogenic therapy for thymic epithelial tumors (TETs): a retrospective study
    Xiang, Jing
    Si, Jinfei
    Hao, Yue
    Wei, Jingwen
    Wang, Wenxian
    Guan, Yelan
    Xu, Chunwei
    Song, Zhengbo
    TRANSLATIONAL CANCER RESEARCH, 2023, 12 (03) : 550 - 557
  • [7] Gut microbiota and efficacy of immune-checkpoint inhibitors (ICIs) in patients (pts) with advanced solid tumor: SCRUM-Japan MONSTAR-SCREEN
    Sawada, K.
    Yamashita, R.
    Horasawa, S.
    Fujisawa, T.
    Yoshikawa, A.
    Nakamura, Y.
    Taniguchi, H.
    Kadowaki, S.
    Hosokawa, M.
    Kodama, T.
    Kato, K.
    Satoh, T.
    Komatsu, Y.
    Shiota, M.
    Yasui, H.
    Yamazaki, K.
    Yoshino, T.
    ANNALS OF ONCOLOGY, 2021, 32 : S382 - S382
  • [8] The impact of sarcopenia on the efficacy and safety of immune checkpoint inhibitors in patients with solid tumours
    Haik, Laura
    Gonthier, Aurore
    Quivy, Amandine
    Gross-goupil, Marine
    Veillon, Remi
    Frison, Eric
    Ravaud, Alain
    Domblides, Charlotte
    Daste, Amaury
    ACTA ONCOLOGICA, 2021, 60 (12) : 1597 - 1603
  • [9] Organ dysfunction (dys) and clinical outcomes in patients (pts) treated with immune checkpoint inhibitors (ICIs).
    Liu, Qi
    Sharon, Elad
    Zineh, Issam
    Xie, Diqiong
    Baxi, Shrujal S.
    Liu, Chao
    Zhi, Jizu
    Torres, Aracelis Z.
    Gossai, Anala
    Sridhara, Rajeshwari
    Booth, Brian
    Blumenthal, Gideon Michael
    Huang, Shiew-Mei
    Khozin, Sean
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [10] Safety and efficacy of immune checkpoint inhibitors (ICIs) in patients with HIV, hepatitis B, or hepatitis C viral infections
    Shah, Neil J.
    AL-Shbool, Ghassan
    Blackburn, Matthew
    Cook, Michael
    Kelly, William J.
    Belouali, Anas
    Ochoa, Sebastian
    Colton, Bradley S.
    Puthiamadathil, Jeevan
    Serzan, Michael T.
    Knoedler, Alice R.
    Liu, Stephen V.
    Pishvaian, Michael J.
    Mohebtash, Mahsa
    Madhavan, Subha
    He, Aiwu R.
    Atkins, Michael B.
    Gibney, Geoffrey T.
    Kim, Chul
    CANCER RESEARCH, 2019, 79 (13)
12345